January 2002
Royal Society of Medicine: Medicines;2002, p421
Reference Entry
The article presents information on Paludrine/Avloclor, a proprietary, non-prescription Travel Pack containing the antimalarial drugs chloroquine, as phosphate, and proguanil hydrochloride. It can be used to prevent or treat certain forms of malaria. It is available as tablets.


Related Articles

  • Case report: Life-threatening hypoglycaemia associated with sulfadoxinepyrimethamine,a commonly used antimalarial drug Fairhurst, R.M.; Sadou, B.; Guindo, A.; Diallo, D.A.; Doumbo, O.K.; Wellems, T.E. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Sep2003, Vol. 97 Issue 5, p595 

    Abstract: Due to chloroquine resistance, several African countries have changed their first-line malaria treatmentto sulfadoxine-pyrimethamine (SP). In this report, we present a case of hypoglycaemic coma associated with SP, an adverse reaction that is likely to be underreported and expected to...

  • Paludrine.  // Royal Society of Medicine: Medicines;2002, p421 

    The article presents information on Paludrine, a proprietary, non-prescription preparation of the antimalarial proguanil hydrochloride. It can be used in the prevention of malaria, and is available as tablets.

  • Factors associated with chloroquine-induced retinopathy in rheumatic diseases. Araiza-Casillas, R.; C�rdenas, F.; Morales, Y.; Cardiel, M. H. // Lupus;2004, Vol. 13 Issue 2, p119 

    Antimalarials are very useful drugs in the treatment of various rheumatic diseases. One of their main side effects is ocular toxicity, specifically retinopathy. Our objective was to identify risk factors associated with chloroquine retinopathy. A single, trained evaluator reviewed patient...

  • Discussion.  // Journal of the Royal Society of Medicine (Supplement);Jul1989, Vol. 82 Issue 17, p33 

    The article presents a discussion among medical experts about antimalarial drugs. It details the major problems related to the side-effects of mefloquine. It emphasises the need for pregnant women to be very careful about antimosquito measures and seek medical advice rapidly if they develop...

  • Malaria Prophylaxis and Treatment in G-6-PD Deficiency. Ziai, M.; Amirhakimi, G. H.; Reinhold, J. G.; Tabatabee, M.; Gettner, M. E.; Bowman, J. E.; Kamal, D. // Clinical Pediatrics;Apr1967, Vol. 6 Issue 4, p242 

    This article investigates the effect of both short and prolonged administration of a mixture of chloroquine base and primaquine base to subjects who were known to have erythrocyte deficiency of glucose-6-phosphate dehydrogenase. This enzyme deficiency is qualitatively and quantitatively not...

  • Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum. Biswas, S. // Journal of Postgraduate Medicine;Jan-Mar2004, Vol. 50 Issue 1, p17 

    Background: Antifolate antimalarials like sulfadoxine-pyrimethamine are used as second-line treatment for Plasmodium falciparum malaria patients who fail to respond to chloroquine. The efficacy of the sulfapyrimethamine combination in the treatment is also compromised by the development of...

  • Transient accumulation of Gallyas-Braak-positive and phosphorylated tau-immunopositive substances in neuronal lipofuscin granules in the amygdala, hippocampus and entorhinal cortex of rats during long-term chloroquine intoxication. Takeuchi, I. K.; Takeuchi, Y. K. // Acta Neuropathologica;Aug2001, Vol. 102 Issue 2, p191 

    Long-term chloroquine (CQ) intoxication of normal and groggy mutant rats resulted in transient accumulation of Gallyas-Braak (G-B) -positive and phosphorylated tau (AT8) -immunopositive substances in neuronal lipofuscin granules in the amygdala, hippocampus and entorhinal cortex. In the facial...

  • Treatment of severe malaria. Warrell, D. A. // Journal of the Royal Society of Medicine (Supplement);Jul1989, Vol. 82 Issue 17, p44 

    In the treatment of severe Plasmodium falciparum infection antimalarial drugs should, ideally, be given by controlled rate intravenous infusion until the patient is able to swallow tablets. In cases where infection has been acquired in a chloroquine resistant area, and where it has broken...

  • Global fund changes tack on malaria therapy. Butler, Declan // Nature;6/10/2004, Vol. 429 Issue 6992, p588 

    Reports on a move to switch malaria treatment in African to a more effective therapy. Agreement of the Geneva-based Global Fund to Fight Aids, Tuberculosis and Malaria to instruct African countries to modify all malaria agents awarded to specify only the newer drug; Resistance of the malaria...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics